Transgenic zebrafish for modeling hepatocellular carcinoma
1Department of Biological Sciences National University of Singapore Singapore.
Abstract:
Liver cancer is the third leading cause of cancer-related deaths throughout the world, and more than 0.6 million people die from liver cancer annually. Therefore, novel therapeutic strategies to eliminate malignant cells from liver cancer patients are urgently needed. Recent advances in high-throughput genomic technologies have identified de novo candidates for oncogenes and pharmacological targets. However, testing and understanding the mechanism of oncogenic transformation as well as probing the kinetics and therapeutic responses of spontaneous tumors in an intact microenvironment require in vivo examination using genetically modified animal models. The zebrafish (Danio rerio) has attracted increasing attention as a new model for studying cancer biology since the organs in the model are strikingly similar to human organs and the model can be genetically modified in a short time and at a low cost. This review summarizes the current knowledge of epidemiological data and genetic alterations in hepatocellular carcinoma (HCC), zebrafish models of HCC, and potential therapeutic strategies for targeting HCC based on knowledge from the models.
Insights
Zebrafish models offer a low-cost, rapid method for studying liver cancer (hepatocellular carcinoma). This review explores genetic alterations, zebrafish models, and therapeutic strategies for this deadly disease.
Area of Science:
- Oncology and Genetics
- Comparative Medicine
Background:
- Liver cancer is a major global health burden, causing over 0.6 million deaths annually.
- Identifying novel therapeutic targets and understanding oncogenic mechanisms require effective in vivo models.
- Genetically modified zebrafish (Danio rerio) are emerging as valuable models for cancer research due to organ similarity and rapid genetic manipulation.
Purpose of the Study:
- To review epidemiological data and genetic alterations in hepatocellular carcinoma (HCC).
- To summarize the utility and application of zebrafish models in HCC research.
- To discuss potential therapeutic strategies for HCC informed by zebrafish studies.
Main Methods:
- Review of existing literature on liver cancer epidemiology, genetics, and zebrafish cancer models.
- Analysis of genetic alterations and oncogene candidates identified through high-throughput genomic technologies.
- Evaluation of spontaneous tumor development and therapeutic responses in genetically modified zebrafish.
Main Results:
- Zebrafish models exhibit organ structures and genetic pathways relevant to human HCC.
- These models allow for rapid, cost-effective in vivo testing of oncogenic mechanisms and drug responses.
- Insights from zebrafish studies are guiding the development of novel therapeutic strategies for liver cancer.
Conclusions:
- Zebrafish represent a powerful preclinical model for advancing liver cancer research.
- Understanding genetic alterations in HCC, coupled with insights from zebrafish models, is crucial for developing effective treatments.
- Further research using zebrafish holds promise for identifying new pharmacological targets and therapeutic interventions for hepatocellular carcinoma.
